DS Healthcare to Announce New Board Members

POMPANO BEACH, FL / ACCESSWIRE / March 31, 2016 / DS Healthcare (NASDAQ: DSKX) shareholders have removed the current Directors Michael Pope, Karl Sweis, and Dianne Rosenfeld in connection with concerns regarding violations of various obligations to shareholders and the resulting rapid decline in DS Healthcare securities and ensuing liabilities. Shareholders have acted via written consent in accordance with company By-Laws.

New Board Members have been proposed by shareholders and will be announced on Monday.

About DS Healthcare Group

DS Healthcare Group Inc. develops novel biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group’s flagship brand, visit www.dslaboratories.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies, and are generally preceded by words such as “future,” “plan” or “planned,” “expects,” or “projected.” These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov

Contact:

Investor Relations
DS Healthcare Group
(888) 404-7770 ext. 3
Investors@DSHealthgroup.com

SOURCE: DS Healthcare Group

ReleaseID: 438352